• In-Network Providers
  • Health Bulletin
  • Publications

Cannabioids Block Cellular Entry Of SARS-CoV-2 and The Emerging Variants

As a complement to vaccines and treatment of SARS-CoV-2 cannaboids which affect the secretion of neurotransmittors in the brain. These botanics exert their activity by spesifically  affecting the membranes of the cells. The cannaboic acids obtained from Cannabis Sativa bind to the Spike protein and neutralize the virüs. These acids also prevent the entrance of alpha and beta variants  into the cell. It is  suggested that cannaboids extracted from hemp may safely be used orally to prevent and treat SARS-Cov-2 infection,  after long periods of studies on humans.

Reference: Cannabioids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants. Richard B, van Breemen, Ruth N. Muchiri, Timothy A. Bates, Jules B.Weinstein, HansC. Leier, Scotland Farley and Fikadu G. Tafesse. Nat. Prod. 2022, 85, 176-84